EXONDYS 51 (ETEPLIRSEN)
Live / Registered — Registered (as of 18 Apr 2023)
What this means for you
Registered since 18 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90857980
- Registration number
- 7032061
- Mark type
- Design + words
- Filed
- 30 Jul 2021
- Published for opposition
- 22 Mar 2022
- Registered
- 18 Apr 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations featuring antisense oligonucleotides for the treatment of neuromuscular diseases and disorders
Owner
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 18 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Feb 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Feb 2023 — ASSIGNED TO LIE
- 15 Dec 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Dec 2022 — NON-FINAL ACTION E-MAILED
- 12 Dec 2022 — SU - NON-FINAL ACTION - WRITTEN
- 24 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Nov 2022 — USE AMENDMENT FILED
- 23 Nov 2022 — SOU EXTENSION 1 GRANTED